(PHI) PLDT - Overview
Stock: Cellular, Broadband, Satellite, IT Services, Content
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 7.61% |
| Yield on Cost 5y | 8.20% |
| Yield CAGR 5y | -0.11% |
| Payout Consistency | 79.8% |
| Payout Ratio | 3.8% |
| Risk 5d forecast | |
|---|---|
| Volatility | 23.9% |
| Relative Tail Risk | -5.11% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.37 |
| Alpha | 4.47 |
| Character TTM | |
|---|---|
| Beta | 0.263 |
| Beta Downside | 0.133 |
| Drawdowns 3y | |
|---|---|
| Max DD | 28.46% |
| CAGR/Max DD | 0.23 |
Description: PHI PLDT January 09, 2026
PLDT Inc. (NYSE:PHI) is the Philippines’ largest integrated telecommunications and digital services provider, operating across Wireless, Fixed Line, and “Other” segments. Its portfolio spans mobile voice and data, broadband internet, satellite messaging, managed IT outsourcing, e-commerce platforms, and a suite of value-added services such as loyalty programs and content distribution.
Key performance indicators as of FY 2023 show ≈ 73 million mobile subscribers and ≈ 13 million fixed-line broadband customers, delivering total revenue of ≈ PHP 420 billion and an EBITDA margin of roughly 38 %. The firm is actively rolling out 5G in major urban centers, a move expected to lift average revenue per user (ARPU) by 4-6 % annually, while the Philippines’ GDP growth of ≈ 5 % in 2023 and rising digital adoption underpin demand for PLDT’s data-centric services.
Sector dynamics include intense competition from Globe Telecom, regulatory pressure on pricing, and a macro-trend toward cloud and data-center services, which together shape PLDT’s strategic focus on high-margin enterprise solutions and cross-border digital platforms.
For a deeper dive into PLDT’s valuation assumptions and scenario analysis, you may find ValueRay’s analyst notes worth reviewing.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income: 29.31b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA -1.67 > 1.0 |
| NWC/Revenue: -46.28% < 20% (prev -59.67%; Δ 13.39% < -1%) |
| CFO/TA 0.14 > 3% & CFO 89.38b > Net Income 29.31b |
| Net Debt (348.20b) to EBITDA (84.48b): 4.12 < 3 |
| Current Ratio: 0.38 > 1.5 & < 3 |
| Outstanding Shares: last quarter (216.6m) vs 12m ago 0.26% < -2% |
| Gross Margin: 75.80% > 18% (prev 0.77%; Δ 7504 % > 0.5%) |
| Asset Turnover: 35.08% > 50% (prev 34.76%; Δ 0.32% > 0%) |
| Interest Coverage Ratio: 6.33 > 6 (EBITDA TTM 84.48b / Interest Expense TTM 8.89b) |
Altman Z'' -0.26
| A: -0.16 (Total Current Assets 61.95b - Total Current Liabilities 163.38b) / Total Assets 629.56b |
| B: 0.06 (Retained Earnings 38.40b / Total Assets 629.56b) |
| C: 0.09 (EBIT TTM 56.25b / Avg Total Assets 624.78b) |
| D: -0.01 (Book Value of Equity -3.99b / Total Liabilities 508.06b) |
| Altman-Z'' Score: -0.26 = B |
Beneish M -3.13
| DSRI: 1.02 (Receivables 31.36b/30.10b, Revenue 219.17b/215.54b) |
| GMI: 1.01 (GM 75.80% / 76.52%) |
| AQI: 0.92 (AQ_t 0.31 / AQ_t-1 0.34) |
| SGI: 1.02 (Revenue 219.17b / 215.54b) |
| TATA: -0.10 (NI 29.31b - CFO 89.38b) / TA 629.56b) |
| Beneish M-Score: -3.13 (Cap -4..+1) = AA |
What is the price of PHI shares?
Over the past week, the price has changed by +6.29%, over one month by +12.64%, over three months by +24.18% and over the past year by +10.50%.
Is PHI a buy, sell or hold?
- StrongBuy: 1
- Buy: 0
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the PHI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 31.1 | 29.7% |
| Analysts Target Price | 31.1 | 29.7% |
| ValueRay Target Price | 25.2 | 4.9% |
PHI Fundamental Data Overview February 03, 2026
P/E Trailing = 9.8087
P/E Forward = 7.8247
P/S = 0.0225
P/B = 2.3961
P/EG = 4.3348
Revenue TTM = 219.17b PHP
EBIT TTM = 56.25b PHP
EBITDA TTM = 84.48b PHP
Long Term Debt = 280.13b PHP (from longTermDebt, last quarter)
Short Term Debt = 26.07b PHP (from shortTermDebt, last quarter)
Debt = 358.29b PHP (from shortLongTermDebtTotal, last quarter)
Net Debt = 348.20b PHP (from netDebt column, last quarter)
Enterprise Value = 645.54b PHP (290.46b + Debt 358.29b - CCE 3.21b)
Interest Coverage Ratio = 6.33 (Ebit TTM 56.25b / Interest Expense TTM 8.89b)
EV/FCF = 36.52x (Enterprise Value 645.54b / FCF TTM 17.68b)
FCF Yield = 2.74% (FCF TTM 17.68b / Enterprise Value 645.54b)
FCF Margin = 8.06% (FCF TTM 17.68b / Revenue TTM 219.17b)
Net Margin = 13.37% (Net Income TTM 29.31b / Revenue TTM 219.17b)
Gross Margin = 75.80% ((Revenue TTM 219.17b - Cost of Revenue TTM 53.04b) / Revenue TTM)
Gross Margin QoQ = 87.53% (prev 86.53%)
Tobins Q-Ratio = 1.03 (Enterprise Value 645.54b / Total Assets 629.56b)
Interest Expense / Debt = 0.02% (Interest Expense 81.9m / Debt 358.29b)
Taxrate = 23.04% (2.08b / 9.04b)
NOPAT = 43.29b (EBIT 56.25b * (1 - 23.04%))
Current Ratio = 0.38 (Total Current Assets 61.95b / Total Current Liabilities 163.38b)
Debt / Equity = 2.98 (Debt 358.29b / totalStockholderEquity, last quarter 120.33b)
Debt / EBITDA = 4.12 (Net Debt 348.20b / EBITDA 84.48b)
Debt / FCF = 19.70 (Net Debt 348.20b / FCF TTM 17.68b)
Total Stockholder Equity = 118.86b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.69% (Net Income 29.31b / Total Assets 629.56b)
RoE = 24.66% (Net Income TTM 29.31b / Total Stockholder Equity 118.86b)
RoCE = 14.10% (EBIT 56.25b / Capital Employed (Equity 118.86b + L.T.Debt 280.13b))
RoIC = 10.64% (NOPAT 43.29b / Invested Capital 406.86b)
WACC = 3.09% (E(290.46b)/V(648.75b) * Re(6.88%) + D(358.29b)/V(648.75b) * Rd(0.02%) * (1-Tc(0.23)))
Discount Rate = 6.88% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 33.33 | Cagr: 0.11%
[DCF Debug] Terminal Value 80.82% ; FCFF base≈21.71b ; Y1≈14.25b ; Y5≈6.50b
Fair Price DCF = N/A (negative equity: EV 207.18b - Net Debt 348.20b = -141.02b; debt exceeds intrinsic value)
[DCF Warning] FCF declining rapidly (-40.0%), DCF may be unreliable
EPS Correlation: 11.75 | EPS CAGR: -10.69% | SUE: -0.04 | # QB: 0
Revenue Correlation: 87.46 | Revenue CAGR: 1.85% | SUE: 2.30 | # QB: 1
EPS next Year (2026-12-31): EPS=2.88 | Chg30d=-0.097 | Revisions Net=-1 | Growth EPS=+5.8% | Growth Revenue=+2.9%